0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Disease Control and Prevention Vaccine - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-10N7023
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Disease Control and Prevention Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Disease Control and Prevention Vaccine - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-10N7023
Report
November 2023
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Disease Control and Prevention Vaccine - Market Size

The global Disease Control and Prevention Vaccine market size is expected to reach US$ 84190 million by 2029, growing at a CAGR of 10.4% from 2023 to 2029.

Disease Control and Prevention Vaccine -  Market

Disease Control and Prevention Vaccine - Market

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
The market is mainly driven by the significant applications of Disease Control and Prevention Vaccine in various end use industries. The expanding demands from the Pediatric Vaccine and Adult Vaccine, are propelling Disease Control and Prevention Vaccine market. Live-Attenuated, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inactivated segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Disease Control and Prevention Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Disease Control and Prevention Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Disease Control and Prevention Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Disease Control and Prevention Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Disease Control and Prevention Vaccine covered in this report include GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd and Daiichi Sankyo, etc.
The global Disease Control and Prevention Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
Abbott Laboratories
Bharat Biotech International
Bavarian Nordic A/S
CSL Limited
Emergent BioSolutions Inc
Inovio Pharmaceuticals Inc
Johnson & Johnson
Mitsubishi Tanabe Pharma Corporation
Novavax Inc
Panacea Biotec Ltd
Takeda Pharmaceutical Company Limited

Scope of Disease Control and Prevention Vaccine - Market Report

Report Metric Details
Report Name Disease Control and Prevention Vaccine - Market
Forecasted market size in 2029 US$ 84190 million
CAGR 10.4%
Forecasted years 2023 - 2029
Global Disease Control and Prevention Vaccine market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Disease Control and Prevention Vaccine market, Segment by Type:
  • Live-Attenuated
  • Inactivated
  • Recombinant Sub Unit and Toxoid
Global Disease Control and Prevention Vaccine market, by Application
  • Pediatric Vaccine
  • Adult Vaccine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Disease Control and Prevention Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Disease Control and Prevention Vaccine - Market size in 2029?

Ans: The Disease Control and Prevention Vaccine - Market size in 2029 will be US$ 84190 million.

What are the Application segmentation covered in the Disease Control and Prevention Vaccine - Market report?

Ans: The Applications covered in the Disease Control and Prevention Vaccine - Market report are Pediatric Vaccine, Adult Vaccine

What are the Type segmentation covered in the Disease Control and Prevention Vaccine - Market report?

Ans: The Types covered in the Disease Control and Prevention Vaccine - Market report are Live-Attenuated, Inactivated, Recombinant Sub Unit and Toxoid

1 Market Overview of Disease Control and Prevention Vaccine
1.1 Disease Control and Prevention Vaccine Market Overview
1.1.1 Disease Control and Prevention Vaccine Product Scope
1.1.2 Disease Control and Prevention Vaccine Market Status and Outlook
1.2 Global Disease Control and Prevention Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Disease Control and Prevention Vaccine Market Size by Region (2018-2029)
1.4 Global Disease Control and Prevention Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Disease Control and Prevention Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Disease Control and Prevention Vaccine Market Size (2018-2029)
1.6.1 North America Disease Control and Prevention Vaccine Market Size (2018-2029)
1.6.2 Europe Disease Control and Prevention Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Disease Control and Prevention Vaccine Market Size (2018-2029)
1.6.4 Latin America Disease Control and Prevention Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Disease Control and Prevention Vaccine Market Size (2018-2029)
2 Disease Control and Prevention Vaccine Market by Type
2.1 Introduction
2.1.1 Live-Attenuated
2.1.2 Inactivated
2.1.3 Recombinant Sub Unit and Toxoid
2.2 Global Disease Control and Prevention Vaccine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Disease Control and Prevention Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Disease Control and Prevention Vaccine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Disease Control and Prevention Vaccine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Disease Control and Prevention Vaccine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Disease Control and Prevention Vaccine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Disease Control and Prevention Vaccine Revenue Breakdown by Type (2018-2029)
3 Disease Control and Prevention Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Pediatric Vaccine
3.1.2 Adult Vaccine
3.2 Global Disease Control and Prevention Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Disease Control and Prevention Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Disease Control and Prevention Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Disease Control and Prevention Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Disease Control and Prevention Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Disease Control and Prevention Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Disease Control and Prevention Vaccine Revenue Breakdown by Application (2018-2029)
4 Disease Control and Prevention Vaccine Competition Analysis by Players
4.1 Global Disease Control and Prevention Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
4.3 Date of Key Players Enter into Disease Control and Prevention Vaccine Market
4.4 Global Top Players Disease Control and Prevention Vaccine Headquarters and Area Served
4.5 Key Players Disease Control and Prevention Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Disease Control and Prevention Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Disease Control and Prevention Vaccine Products, Services and Solutions
5.1.4 GSK Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Merck & Co., Inc
5.2.1 Merck & Co., Inc Profile
5.2.2 Merck & Co., Inc Main Business
5.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Products, Services and Solutions
5.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Merck & Co., Inc Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Disease Control and Prevention Vaccine Products, Services and Solutions
5.3.4 Pfizer Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Disease Control and Prevention Vaccine Products, Services and Solutions
5.4.4 Sanofi Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 AstraZeneca PLC
5.5.1 AstraZeneca PLC Profile
5.5.2 AstraZeneca PLC Main Business
5.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Products, Services and Solutions
5.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 AstraZeneca PLC Recent Developments
5.6 Sinovac Biotech Ltd
5.6.1 Sinovac Biotech Ltd Profile
5.6.2 Sinovac Biotech Ltd Main Business
5.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
5.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 Sinovac Biotech Ltd Recent Developments
5.7 Astellas Pharma Inc
5.7.1 Astellas Pharma Inc Profile
5.7.2 Astellas Pharma Inc Main Business
5.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Products, Services and Solutions
5.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.7.5 Astellas Pharma Inc Recent Developments
5.8 Serum Institute of India Pvt. Ltd
5.8.1 Serum Institute of India Pvt. Ltd Profile
5.8.2 Serum Institute of India Pvt. Ltd Main Business
5.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
5.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.8.5 Serum Institute of India Pvt. Ltd Recent Developments
5.9 Daiichi Sankyo
5.9.1 Daiichi Sankyo Profile
5.9.2 Daiichi Sankyo Main Business
5.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Products, Services and Solutions
5.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.9.5 Daiichi Sankyo Recent Developments
5.10 Abbott Laboratories
5.10.1 Abbott Laboratories Profile
5.10.2 Abbott Laboratories Main Business
5.10.3 Abbott Laboratories Disease Control and Prevention Vaccine Products, Services and Solutions
5.10.4 Abbott Laboratories Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.10.5 Abbott Laboratories Recent Developments
5.11 Bharat Biotech International
5.11.1 Bharat Biotech International Profile
5.11.2 Bharat Biotech International Main Business
5.11.3 Bharat Biotech International Disease Control and Prevention Vaccine Products, Services and Solutions
5.11.4 Bharat Biotech International Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.11.5 Bharat Biotech International Recent Developments
5.12 Bavarian Nordic A/S
5.12.1 Bavarian Nordic A/S Profile
5.12.2 Bavarian Nordic A/S Main Business
5.12.3 Bavarian Nordic A/S Disease Control and Prevention Vaccine Products, Services and Solutions
5.12.4 Bavarian Nordic A/S Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.12.5 Bavarian Nordic A/S Recent Developments
5.13 CSL Limited
5.13.1 CSL Limited Profile
5.13.2 CSL Limited Main Business
5.13.3 CSL Limited Disease Control and Prevention Vaccine Products, Services and Solutions
5.13.4 CSL Limited Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.13.5 CSL Limited Recent Developments
5.14 Emergent BioSolutions Inc
5.14.1 Emergent BioSolutions Inc Profile
5.14.2 Emergent BioSolutions Inc Main Business
5.14.3 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Products, Services and Solutions
5.14.4 Emergent BioSolutions Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.14.5 Emergent BioSolutions Inc Recent Developments
5.15 Inovio Pharmaceuticals Inc
5.15.1 Inovio Pharmaceuticals Inc Profile
5.15.2 Inovio Pharmaceuticals Inc Main Business
5.15.3 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Products, Services and Solutions
5.15.4 Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.15.5 Inovio Pharmaceuticals Inc Recent Developments
5.16 Johnson & Johnson
5.16.1 Johnson & Johnson Profile
5.16.2 Johnson & Johnson Main Business
5.16.3 Johnson & Johnson Disease Control and Prevention Vaccine Products, Services and Solutions
5.16.4 Johnson & Johnson Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.16.5 Johnson & Johnson Recent Developments
5.17 Mitsubishi Tanabe Pharma Corporation
5.17.1 Mitsubishi Tanabe Pharma Corporation Profile
5.17.2 Mitsubishi Tanabe Pharma Corporation Main Business
5.17.3 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Products, Services and Solutions
5.17.4 Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.17.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
5.18 Novavax Inc
5.18.1 Novavax Inc Profile
5.18.2 Novavax Inc Main Business
5.18.3 Novavax Inc Disease Control and Prevention Vaccine Products, Services and Solutions
5.18.4 Novavax Inc Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.18.5 Novavax Inc Recent Developments
5.19 Panacea Biotec Ltd
5.19.1 Panacea Biotec Ltd Profile
5.19.2 Panacea Biotec Ltd Main Business
5.19.3 Panacea Biotec Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
5.19.4 Panacea Biotec Ltd Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.19.5 Panacea Biotec Ltd Recent Developments
5.20 Takeda Pharmaceutical Company Limited
5.20.1 Takeda Pharmaceutical Company Limited Profile
5.20.2 Takeda Pharmaceutical Company Limited Main Business
5.20.3 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Products, Services and Solutions
5.20.4 Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Revenue (US$ Million) & (2018-2023)
5.20.5 Takeda Pharmaceutical Company Limited Recent Developments
6 North America
6.1 North America Disease Control and Prevention Vaccine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Disease Control and Prevention Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Disease Control and Prevention Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Disease Control and Prevention Vaccine Market Dynamics
11.1 Disease Control and Prevention Vaccine Industry Trends
11.2 Disease Control and Prevention Vaccine Market Drivers
11.3 Disease Control and Prevention Vaccine Market Challenges
11.4 Disease Control and Prevention Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Disease Control and Prevention Vaccine Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Disease Control and Prevention Vaccine Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Disease Control and Prevention Vaccine Market Size Share by Region (2018-2023)
    Table 4. Global Disease Control and Prevention Vaccine Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Disease Control and Prevention Vaccine Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Disease Control and Prevention Vaccine Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Disease Control and Prevention Vaccine Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2023)
    Table 9. Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Disease Control and Prevention Vaccine Revenue Market Share by Type (2024-2029)
    Table 11. North America Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Disease Control and Prevention Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Disease Control and Prevention Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Disease Control and Prevention Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Disease Control and Prevention Vaccine Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Disease Control and Prevention Vaccine Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2023)
    Table 24. Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Disease Control and Prevention Vaccine Revenue Market Share by Application (2024-2029)
    Table 26. North America Disease Control and Prevention Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Disease Control and Prevention Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Disease Control and Prevention Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Disease Control and Prevention Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Disease Control and Prevention Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Disease Control and Prevention Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Disease Control and Prevention Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Disease Control and Prevention Vaccine Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Disease Control and Prevention Vaccine Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Disease Control and Prevention Vaccine Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
    Table 39. Date of Key Players Enter into Disease Control and Prevention Vaccine Market
    Table 40. Global Disease Control and Prevention Vaccine Key Players Headquarters and Area Served
    Table 41. Disease Control and Prevention Vaccine Product Solution and Service
    Table 42. Global Disease Control and Prevention Vaccine Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. GSK Basic Information List
    Table 45. GSK Description and Business Overview
    Table 46. GSK Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of GSK (2018-2023)
    Table 48. GSK Recent Developments
    Table 49. Merck & Co., Inc Basic Information List
    Table 50. Merck & Co., Inc Description and Business Overview
    Table 51. Merck & Co., Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Merck & Co., Inc (2018-2023)
    Table 53. Merck & Co., Inc Recent Developments
    Table 54. Pfizer Basic Information List
    Table 55. Pfizer Description and Business Overview
    Table 56. Pfizer Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Pfizer (2018-2023)
    Table 58. Pfizer Recent Developments
    Table 59. Sanofi Basic Information List
    Table 60. Sanofi Description and Business Overview
    Table 61. Sanofi Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Sanofi (2018-2023)
    Table 63. Sanofi Recent Developments
    Table 64. AstraZeneca PLC Basic Information List
    Table 65. AstraZeneca PLC Description and Business Overview
    Table 66. AstraZeneca PLC Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of AstraZeneca PLC (2018-2023)
    Table 68. AstraZeneca PLC Recent Developments
    Table 69. Sinovac Biotech Ltd Basic Information List
    Table 70. Sinovac Biotech Ltd Description and Business Overview
    Table 71. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Sinovac Biotech Ltd (2018-2023)
    Table 73. Sinovac Biotech Ltd Recent Developments
    Table 74. Astellas Pharma Inc Basic Information List
    Table 75. Astellas Pharma Inc Description and Business Overview
    Table 76. Astellas Pharma Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Astellas Pharma Inc (2018-2023)
    Table 78. Astellas Pharma Inc Recent Developments
    Table 79. Serum Institute of India Pvt. Ltd Basic Information List
    Table 80. Serum Institute of India Pvt. Ltd Description and Business Overview
    Table 81. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Serum Institute of India Pvt. Ltd (2018-2023)
    Table 83. Serum Institute of India Pvt. Ltd Recent Developments
    Table 84. Daiichi Sankyo Basic Information List
    Table 85. Daiichi Sankyo Description and Business Overview
    Table 86. Daiichi Sankyo Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Daiichi Sankyo (2018-2023)
    Table 88. Daiichi Sankyo Recent Developments
    Table 89. Abbott Laboratories Basic Information List
    Table 90. Abbott Laboratories Description and Business Overview
    Table 91. Abbott Laboratories Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Abbott Laboratories (2018-2023)
    Table 93. Abbott Laboratories Recent Developments
    Table 94. Bharat Biotech International Basic Information List
    Table 95. Bharat Biotech International Description and Business Overview
    Table 96. Bharat Biotech International Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Bharat Biotech International (2018-2023)
    Table 98. Bharat Biotech International Recent Developments
    Table 99. Bavarian Nordic A/S Basic Information List
    Table 100. Bavarian Nordic A/S Description and Business Overview
    Table 101. Bavarian Nordic A/S Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Bavarian Nordic A/S (2018-2023)
    Table 103. Bavarian Nordic A/S Recent Developments
    Table 104. CSL Limited Basic Information List
    Table 105. CSL Limited Description and Business Overview
    Table 106. CSL Limited Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of CSL Limited (2018-2023)
    Table 108. CSL Limited Recent Developments
    Table 109. Emergent BioSolutions Inc Basic Information List
    Table 110. Emergent BioSolutions Inc Description and Business Overview
    Table 111. Emergent BioSolutions Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Emergent BioSolutions Inc (2018-2023)
    Table 113. Emergent BioSolutions Inc Recent Developments
    Table 114. Inovio Pharmaceuticals Inc Basic Information List
    Table 115. Inovio Pharmaceuticals Inc Description and Business Overview
    Table 116. Inovio Pharmaceuticals Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Inovio Pharmaceuticals Inc (2018-2023)
    Table 118. Inovio Pharmaceuticals Inc Recent Developments
    Table 119. Johnson & Johnson Basic Information List
    Table 120. Johnson & Johnson Description and Business Overview
    Table 121. Johnson & Johnson Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Johnson & Johnson (2018-2023)
    Table 123. Johnson & Johnson Recent Developments
    Table 124. Mitsubishi Tanabe Pharma Corporation Basic Information List
    Table 125. Mitsubishi Tanabe Pharma Corporation Description and Business Overview
    Table 126. Mitsubishi Tanabe Pharma Corporation Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Mitsubishi Tanabe Pharma Corporation (2018-2023)
    Table 128. Mitsubishi Tanabe Pharma Corporation Recent Developments
    Table 129. Novavax Inc Basic Information List
    Table 130. Novavax Inc Description and Business Overview
    Table 131. Novavax Inc Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Novavax Inc (2018-2023)
    Table 133. Novavax Inc Recent Developments
    Table 134. Panacea Biotec Ltd Basic Information List
    Table 135. Panacea Biotec Ltd Description and Business Overview
    Table 136. Panacea Biotec Ltd Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Panacea Biotec Ltd (2018-2023)
    Table 138. Panacea Biotec Ltd Recent Developments
    Table 139. Takeda Pharmaceutical Company Limited Basic Information List
    Table 140. Takeda Pharmaceutical Company Limited Description and Business Overview
    Table 141. Takeda Pharmaceutical Company Limited Disease Control and Prevention Vaccine Products, Services and Solutions
    Table 142. Revenue (US$ Million) in Disease Control and Prevention Vaccine Business of Takeda Pharmaceutical Company Limited (2018-2023)
    Table 143. Takeda Pharmaceutical Company Limited Recent Developments
    Table 144. North America Disease Control and Prevention Vaccine Market Size by Country (2018-2023) & (US$ Million)
    Table 145. North America Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
    Table 146. Europe Disease Control and Prevention Vaccine Market Size by Country (2018-2023) & (US$ Million)
    Table 147. Europe Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
    Table 148. Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 149. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2018-2023) & (US$ Million)
    Table 150. Asia-Pacific Disease Control and Prevention Vaccine Market Size by Region (2024-2029) & (US$ Million)
    Table 151. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Region (2018-2023)
    Table 152. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Region (2024-2029)
    Table 153. Latin America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 154. Latin America Disease Control and Prevention Vaccine Market Size by Country (2018-2023) & (US$ Million)
    Table 155. Latin America Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
    Table 156. Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 157. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2018-2023) & (US$ Million)
    Table 158. Middle East & Africa Disease Control and Prevention Vaccine Market Size by Country (2024-2029) & (US$ Million)
    Table 159. Disease Control and Prevention Vaccine Market Trends
    Table 160. Disease Control and Prevention Vaccine Market Drivers
    Table 161. Disease Control and Prevention Vaccine Market Challenges
    Table 162. Disease Control and Prevention Vaccine Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Disease Control and Prevention Vaccine Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Disease Control and Prevention Vaccine Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Disease Control and Prevention Vaccine Market Share by Regions: 2022 VS 2029
    Figure 4. Global Disease Control and Prevention Vaccine Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Disease Control and Prevention Vaccine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Disease Control and Prevention Vaccine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Disease Control and Prevention Vaccine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Disease Control and Prevention Vaccine Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Live-Attenuated
    Figure 11. Global Live-Attenuated Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Inactivated
    Figure 13. Global Inactivated Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Recombinant Sub Unit and Toxoid
    Figure 15. Global Recombinant Sub Unit and Toxoid Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Disease Control and Prevention Vaccine Market Size Share by Type: 2022 & 2029
    Figure 17. North America Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Type (2018-2029)
    Figure 22. Pediatric Vaccine Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Adult Vaccine Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Global Disease Control and Prevention Vaccine Market Size Share by Application: 2022 & 2029
    Figure 25. North America Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2029)
    Figure 26. Europe Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2029)
    Figure 27. Asia-Pacific Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2029)
    Figure 28. Latin America Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2029)
    Figure 29. Middle East and Africa Disease Control and Prevention Vaccine Revenue Market Share by Application (2018-2029)
    Figure 30. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 31. Global Top 5 and Top 10 Players Disease Control and Prevention Vaccine Market Share in 2022
    Figure 32. North America Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
    Figure 33. U.S. Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 34. Canada Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 35. Germany Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 36. France Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 37. U.K. Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 38. Italy Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 39. Russia Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 40. Nordic Countries Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 41. Asia-Pacific Disease Control and Prevention Vaccine Market Share by Region (2018-2029)
    Figure 42. China Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 43. Japan Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 44. South Korea Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 46. India Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 47. Australia Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 48. Latin America Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
    Figure 49. Mexico Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 50. Brazil Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Disease Control and Prevention Vaccine Market Share by Country (2018-2029)
    Figure 52. Turkey Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 54. UAE Disease Control and Prevention Vaccine Market Size (2018-2029) & (US$ Million)
    Figure 55. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS